MAXILLARY DISTRACTOR

June 1, 2016

The Maxillary Distractor can be customized to meet the anatomical needs of pediatric and adult patients, based on preoperative treatment planning. Distraction of the maxilla is accomplished bilaterally using a left and a right assembly. The Maxillary Distractor is intended for use as a bone stabilizer and lengthening device, where gradual bone distraction is required. The Maxillary Distractor is indicated for use in craniofacial surgery, reconstructive procedures, and selective orthognathic surgery of the maxilla. Specifically, it is intended for distraction of the maxilla utilizing a LeFort I osteotomy in adult and pediatric populations.

Spotlight

Verséa Health

Verséa, is a US-based healthcare company is comprised of 4 divisions: Verséa Therapeutics, Verséa Diagnostics, Verséa Scientific Discovery & Verséa Ophthalmics. Regardless of which vertical within Verséa, our committed medical and executive team focus on transformative health solutions for patients, caregivers and healthcare professionals, delivered with care.

OTHER WHITEPAPERS
news image

How health systems can recover millions in lost revenue

whitePaper | February 5, 2020

The landscape of healthcare revenue appears bleak: costs and expenses are rising, while reimbursements decline. Traditionally, solutions focus on preventative measures, yet costly write-offs remain ever-present. This is especially true with respect to commercial claims, where denials are plentiful and appeals complicated and labor intensive. How, then, can you mitigate loss without straining your resources? One answer is claims appeals through the Federal ERISA process. Through specialization in Federal ERISA Law, the experienced staff of ERISA Recovery can collect on aged claims without undue burden on your systems.

Read More
news image

CURRENT AND EMERGING HEALTHCARE CYBER THREAT LANDSCAPE

whitePaper | March 24, 2022

2021 was a challenging year in cybersecurity with several high-profile compromises involving large vendors and large-scale vulnerabilities.

Read More
news image

Addressing Total Cost of Care Across the Specialty Population

whitePaper | September 28, 2022

Specialty drugs span a wide range of disease states, from the more prevalent, yet complex, such as multiple sclerosis, to rare and orphan diseases, such as hereditary angioedema (HAE).

Read More
news image

C-suite check-in: The healthcare workforce crisis

whitePaper | December 15, 2022

Every segment in health care is experiencing extraordinary changes in the workforce. Burnout, turnover, rising labor costs and skill gaps are diminishing the supply of qualified workers.

Read More
news image

Clearing hurdles that crimp real-time and predictive insights in healthcare

whitePaper | July 26, 2022

Healthcare leaders have long recognized the importance of real-time decision making. Take, for instance, sepsis one of the leading causes of U.S. hospital deaths that costs the industry an estimated $62B a year,1 not to mention the preventable morbidity

Read More
news image

Reimagining the Healthcare Digital Experience

whitePaper | December 22, 2022

In seven taps taking less than fifteen seconds your customized coffee order is being prepared and will be waiting with your name on it at the shop down the block. In four taps your favorite sandwich is being driven to your office. One button click on your TV remote fills the screen with hundreds.

Read More

Spotlight

Verséa Health

Verséa, is a US-based healthcare company is comprised of 4 divisions: Verséa Therapeutics, Verséa Diagnostics, Verséa Scientific Discovery & Verséa Ophthalmics. Regardless of which vertical within Verséa, our committed medical and executive team focus on transformative health solutions for patients, caregivers and healthcare professionals, delivered with care.

Events